# Oral Dosage Form New Animal Drugs; Albendazole Suspension
> **Food and Drug Administration** · Final rule. · Published 1999-01-11 · Effective 1999-01-11 · 64 FR 1503
## Document
- **Document number:** 99-449
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 1503
- **CFR reference:** 21 CFR 520
- **Publication date:** 1999-01-11
- **Effective date:** 1999-01-11
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA provides for anthelmintic use of the 11.36 percent albendazole suspension in sheep. Based on FDA's review of the data and information in the NADA, a tolerance for drug residues in muscle and an acceptable daily intake (ADI) are established.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/01/11/99-449/oral-dosage-form-new-animal-drugs-albendazole-suspension)
---
*AI Analytics · CC0 1.0*